Skip to content
Breaking

COVID-19: Mutation of Kent variant detected in samples could help virus evade immune system

The variant means the virus has developed a 'superpower' which allows it to change shape so antibodies don't recognise it

JANUARY 28th 2021: The COVID-19 vaccine made by Pfizer and BioNTech appears to retain its effectiveness against the coronavirus variant mutations that have recently emerged in The United Kingdom and South Africa, according to a press release from the firms. - File Photo by: zz/STRF/STAR MAX/IPx 2020 12/18/20 Pfizer Inc. continues the initial rollout and worldwide distribution of the Pfizer-BioNTech COVID-19 vaccine. Here, a view of Pfizer World Headquarters in Midtown Manhattan, New York City on
Image: The newly-discovered mutation is known as E484K
Why you can trust Sky News

A mutation of the Kent COVID variant that has been detected in some samples could help the virus evade the immune system, scientists have found.

The mutation, which has been labelled E484K, has also been found in the South Africa variant of the coronavirus.

It was found in 11 samples of some 200,000 that have been sequenced.

Sky's science correspondent Thomas Moore said it was a "worrying development" as it could mean those previously infected could be re-infected and could reduce the effectiveness of COVID vaccines.

He said the evolution of E484K meant the virus had effectively "developed a superpower" which enabled it to not only infect cells, but also to invade the immune system.

"It changes shape so antibodies don't recognise it in the same way, and the fact that this mutation has been now picked up in some samples of the Kent variant is a twist - a worrying development.

"It potentially means that people who have had the infection before, might be re-infected and also that it might reduce the effectiveness of the vaccine - not completely; the vaccine would still protects against serious infection and death - but perhaps that it wouldn't stop it spreading."